• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1700057 重组全人源抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2017-07-20 上海华奥泰生物药业有限公司 Shanghai Huaota Biopharmaceutical Co Ltd Certificate Issued 2018-06-28 view
CXSL1500080 重组全人源抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-10-19 上海华奥泰生物药业有限公司 Shanghai Huaota Biopharmaceutical Co Ltd Certificate Issued 2016-12-30 view